Connor, Clark & Lunn Investment Management (CC&L)’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,890
Closed -$278K 1412
2023
Q1
$278K Sell
8,890
-11,271
-56% -$353K ﹤0.01% 1020
2022
Q4
$1.42M Sell
20,161
-7,107
-26% -$500K 0.01% 619
2022
Q3
$2.35M Buy
27,268
+3,032
+13% +$261K 0.02% 466
2022
Q2
$2M Buy
+24,236
New +$2M 0.01% 469